πͺ PROSPECTOR-2 is now >85% recruited!
The first international multicentre, double-blind, placebo-controlled trial in drug allergy is tackling an age-old question: βIs one dose enough?β
Balancing antibiotic exposure against allergy risk.
Exciting results ahead. Stay tuned!
#PenicillinAllergy #DrugAllergy #AntimicrobialStewardship
The first international multicentre, double-blind, placebo-controlled trial in drug allergy is tackling an age-old question: βIs one dose enough?β
Balancing antibiotic exposure against allergy risk.
Exciting results ahead. Stay tuned!
#PenicillinAllergy #DrugAllergy #AntimicrobialStewardship